APR 22, 2016 6:37 AM PDT

Common Aspirin Linked to Prolonged Cancer Survival

WRITTEN BY: Xuan Pham
Low-dose aspirin as an anti-cancer treatment?
Aspirin, formally known as acetylsalicylic acid (ASA), is one of the cheapest and most widely used over-the-counter drugs. This humble drug is used to treat a variety of health conditions like the common fevers, headaches, and inflammation. Doctors also prescribe this drug to reduce the risk of heart attacks for patients who have already had one.
 
In recent years, aspirin gained the spotlight again as more research linked it to anti-cancer potential. "There is a growing body of evidence that taking aspirin is of significant benefit in reducing some cancers," said Peter Elwood, professor at Cardiff University and first study author. Indeed, studies have previously linked aspirin to lowering the risks for colorectal and colon cancer by close to 20 percent. Likely, aspirin’s anti-inflammatory and anti-clotting properties play a part in its anti-cancer effects.
 
But the exact role of aspirin in cancer remains vague, as no one has really studied this link in depth.  "Whilst we know a low-dose of aspirin has been shown to reduce the incidence of cancer, its role in the treatment of cancer remains uncertain. As a result, we set out to conduct a systematic search of all the scientific literature," said Elwood.
 
To answer this question, Elwood and his team analyzed previous available data from 42 observational studies and 5 randomized trials of colorectal, breast and prostate cancers.
 
They found a 15-20 percent survival increase in patients who took low-dose aspirin, as compared to those who didn’t. Notably, Elwood highlighted the finding that cancer spread was also reduced with aspirin intake, suggesting the drug may reduce cancer metastasis.
 
 "Our review, based on the available evidence, suggests that low-dose aspirin taken by patients with bowel, breast or prostate cancer, in addition to other treatments, is associated with a reduction in deaths of about 15-20%, together with a reduction in the spread of the cancer,” said Elwood.
 
Though the team did not elaborate on mechanisms behind aspirin’s purported anti-cancer effects, they noted a genetic link between a mutation in the PI3KCA gene in about 20 percent of patients. “This appeared to explain much of the reduction in colon cancer mortality by aspirin,” said Elwood.
 
But before we hail aspirin as the miracle wonder drug, it’s important to remember this drug has serious side effects associated with long-term regular use. A daily dose of aspirin, even in its coated form, has the tendency to thin the stomach lining, increasing the risk of gastrointestinal bleeding and stomach inflammation. Stomach bleeding is no trivial matter, as it kills more Americans each year than asthma or cervical cancer.
 
Commenting on the health risks of aspirin, the authors concluded: "While there is a desperate need for more detailed research to verify our review and to obtain evidence on less common cancers, we'd urge patients diagnosed with cancer to speak to their doctor about our findings so they can make an informed decision as to whether or not they should take a low-dose aspirin as part of their cancer treatment.”
 

Additional sources: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 19, 2021
Cancer
Japanese Berry Vine Could Treat Lung Cancer
AUG 19, 2021
Japanese Berry Vine Could Treat Lung Cancer
A berry-producing vine in Japan has shown promise in mouse models for treating lung cancer. The corresponding study was ...
AUG 18, 2021
Cell & Molecular Biology
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
AUG 18, 2021
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
For many years, researchers have studied how an enzyme called APOBEC3 can help protect the body from pathogenic viruses, ...
AUG 29, 2021
Cancer
Researchers Bioprint Deadly Brain Tumor with 3D Printer
AUG 29, 2021
Researchers Bioprint Deadly Brain Tumor with 3D Printer
Researchers have managed to print an entire active and viable glioblastoma tumor- the deadliest form of brain cancer- us ...
SEP 23, 2021
Drug Discovery & Development
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
SEP 23, 2021
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
Last week, the United States Food and Drug Administration (FDA) granted approval for the first oral therapy to ...
OCT 12, 2021
Immunology
Cancer Drug Helps Alzheimer's Mice Remember
OCT 12, 2021
Cancer Drug Helps Alzheimer's Mice Remember
What if a drug—specifically developed to treat one disease—had the potential to address other non-related co ...
OCT 25, 2021
Cell & Molecular Biology
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
OCT 25, 2021
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
Labroots virtual events are a great place to share research and learn about others work. These events feature participan ...
Loading Comments...